The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020
The pharma companies will bring quality products at competitive prices to consumers in Oman and help bring down the cost of healthcare
India has the second-largest number of adults with diabetes globally, after China
Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
It is the first hospital in the country to achieve the significant milestone of completing over 2600 robotic surgeries for treating patients with prostate, kidney and urinary bladder cancer
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
Subscribe To Our Newsletter & Stay Updated
